Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill Patients.
Diagnostics (Basel)
; 12(1)2021 12 28.
Article
in En
| MEDLINE
| ID: mdl-35054232
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Diagnostics (Basel)
Year:
2021
Type:
Article
Affiliation country:
Germany